Suppression of Helicobacter pylori-induced interleukin-8 production in vitro and within the gastric mucosa by a live Lactobacillus strain

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 9, 2006, Pages 1399-1406

  Tamura, Akira ^a,b   Kumai, Hideshi ^b   Nakamichi, Noboru ^b   Sugiyama, Toshirou ^c   Deguchi, Ryozo ^a   Takagi, Atsusi ^a   Koga, Yasuhiro ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIJI DAIRIES CORPORATION   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

H. pylori; IL 8; Lactobacillus; Probiotics; Stomach

Indexed keywords

INTERLEUKIN 8; MESSENGER RNA; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTERIUM ADHERENCE; CLINICAL ARTICLE; CLINICAL TRIAL; COCULTURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; FEMALE; GENETIC TRANSCRIPTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LACTOBACILLUS GASSERI; MALE; NONHUMAN; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH MUCOSA; ULTRAVIOLET RADIATION;

EID: 33746600634     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04318.x     Document Type: Article

References (25)

1. Crabtree JE, Lindley IJ. Mucosal interleukin-8 and Helicobacter pylori-associated gastroduodenal disease. Eur. J. Gastroenterol. Hepatol. 1994; 6: S33-8.
2. Ando TK, Kusugami M, Ohsuga K. Differential normalization of mucosal interleukin-8 and interleukin-6 activity after Helicobacter pylori eradication. Infect. Immun. 1998; 66: 4742-7.
3. Sharma AC, Tummuru MKK, Miller GC et al. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect. Immun. 1995; 63: 1681-7.
4. Censini S, Lange C, Xiang Z et al. cag, a pathogenicity island of Helicobacter pylori, encodes type 1-specific and disease-associated virulence factors. Proc. Natl Acad. Sci. USA 1996; 93: 14648-53.
5. Yamaoka S, Kwon DH, Graham DY. A Mr 34 000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc. Natl Acad. Sci. USA 2000; 97: 7533-8.
6. Kabir AMA, Aiba Y, Takagi A et al. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997; 41: 49-55.
7. Sakamoto I, Igarashi M, Kimura K et al. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J. Antimicrob. Chemother. 2001; 47: 709-10.
8. Samloff I, Varis MK, Ihamaki T et al. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982; 83: 204-9.
9. Khulusi S, Mendall MA, Patel P et al. Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects. Gut 1995; 37: 319-24.
10. Mizushima T, Sugiyama T, Kobayashi T et al. Decreased adherence of cagG-deleted Helicobacter pylori to gastric epithelial cells in Japanese clinical isolates. Helicobacter 2002; 7: 22-9.
11. Kawahara T, Teshima S, Oka A et al. Type I Helicobacter pylori liposaccharide stimulates Toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect. Immun. 2001; 69: 4382-9.
12. Koga Y, Sasaki M, Yoshida H et al. Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV. J. Immunol. 1990; 144: 94-102.
13. Nakamichi N, Ito M, Maeda T et al. Detection and cDNA cloning of H-strand mitochondrial regulatory region RNAs in cultured human cells and human tissues. Cytotechnology 2000; 33: 175-88.
14. Crabtree JE, Peichl P, Wyatt JI et al. Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand. J. Immunol. 1993; 37: 65-70.
15. Bhatia SJ, Kochar N, Abraham P et al. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J. Clin. Microbiol. 1989; 27: 2328-30.
16. Midolo PD, Lambert JR, Hull R et al. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J. Appl. Bacteriol. 1995; 79: 475-9.
17. Rieder G, Hatz RA, Moran AP et al. Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis. Infect. Immun. 1997; 65: 3622-30.
18. Bernet MF, Brassart D, Neeser JR et al. Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35: 483-9.
19. Censini S, Lange C, Xiang Z et al. cag, a pathogenicity island of Helicobacter pylori, encodes type 1-specific and disease-associated virulent factors. Proc. Natl Acad. Sci. USA 1996; 93: 14 648-53.
20. Covacci A, Telford JL, Del Giudice G et al. Helicobater pylori virulence and genetic geography. Science 1999; 284: 1328-33.
21. Tummuru MKR, Sharma SA, Blaser MJ. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol. Microbiol. 1995; 18: 867-76.
22. Sharma SA, Tummuru MKR, Blaser MJ et al. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-κB in gastric epithelial cells. J. Immunol. 1998; 160: 2401-7.
23. Yasumoto K, Okamoto S, Mukaida N et al. Tumor necrosis factor α and interferon γ synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J. Biol. Chem. 1992; 31: 22 506-11.
24. Barefoot SF, Nettles CG. Antibiosis revisited; bacteriocins produced by dairy starter cultures. J. Dairy Sci. 1993; 76: 2366-79.
25. Aiba Y, Suzuki N, Kabir AMA et al. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am. J. Gastroenterol. 1998; 93: 2097-101.